| Abstract |
This case aims to document the transformation of Indian Organic Chemicals Limited (a low value high volume bulk chemical producer) into its new avatar as Innovassynth Technologies (I) Ltd, a niche boutique firm in speciality pharmaceutical chemicals in the life sciences industry. Innovassynth is the first Indian company to establish a new kind of research and development process that contracts for co-evolution of capabilities in partnership with large pharma giants like Pfizer and BASF along knowledge-intensive business pathways. The case of this nature tracks the complexities underpinning the co-evolution of dynamic capabilities and challenges the conventional resource-based view of the firm. Here is an opportunity to study how the firm as a nexus of treaties (in the Aokian framework) engages with normative, existential, phenomenal, and hermneneutic primary tasks as conceptualized in the open systems literature. |